Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era-Reference-Cited by-同舟云学术

Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era

Published:2011-03 Issue:2 Volume:23 Page:209-213
ISSN:1040-8746
Container-title:Current Opinion in Oncology
language:en
Short-container-title:

Author:

Mounier Nicolas,Gisselbrecht Christian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference24 articles.

1. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP;Sehn;Blood,2007

2. High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma: results of a comprehensive meta-analysis;Greb;Cancer Treat Rev,2007

3. Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma;Haioun;Ann Oncol,2009

4. Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi);Tarella;Leukemia,2007

5. Benefit of rituximab combined with ACVBP (R-ACVBP) over ACVBP in 209 poor-risk BDLC NHL patients treated with up-front consolidative autotransplantation: a GELA phase II trial (LNH 2003-3). American Society of Clinical Oncology. 45th Annual Meeting, Abstract 8507;Mounier;J Clin Oncol,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP;Leukemia & Lymphoma;2020-01-06

2. Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy;Annals of Hematology;2014-12-14

3. The role of allogeneic haematopoietic progenitor cell transplantation in patients with diffuse large B-cell non-Hodgkin lymphomas (DLBCL);Bone Marrow Transplantation;2013-01-14

4. Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era;American Journal of Hematology;2012-05-28

5. Malignancy-associated chylothorax: a 20-year study of 18 patients from a single institution;European Journal of Cancer Care;2012-02-06